SWOG clinical trial number
SWOG-9216 (INT-0131) (NCIC-CTG-BR.8)

A Randomized Phase III Study of CODE Plus Thoracic Irradiation Versus Alternating CAV and EP for Extensive Stage Small Cell Lung Cancer, (NCIC CTG)

Closed
Phase
Published
Abbreviated Title
A Randomized Phase III Study of CODE Plus Thoracic Irradiation Versus Alternating CAV and EP for Extensive Stage Small Cell Lung Cancer, (NCIC CTG)
Activated
12/15/1992
Closed
04/26/1996

Research committees

Lung Cancer

Publication Information Expand/Collapse

1999

Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical trials group and the Southwest Oncology Group.

N Murray;RB Livingston;FA Shepherd;K James;B Zee;A Langleben;M Kraut;J Bearden;JW Goodwin;C Grafton;A Turrisi;D Walde;H Croft;J Ottaway;D Gandara Journal of Clinical Oncology 17(8):2300-2308

1997

A randomized study of CODE plus thoracic irradiation versus alternating CAV/EP for extensive stage small cell lung cancer

N Murray;R Livingston;F Shepherd;K James;B Zee;A Langleben;M Kraut;J Bearden;J Goodwin;C Grafton;A Turrisi;D Walde;H Croft;J Ottaway Proc of the American Society of Clinical Oncology 16:456a(#1638)

1996

Pilot study of cisplatin, doxorubicin, vincristine and etoposide (PAVE) in elderly and frail patients with small cell lung cancer (SCLC).

V Westeel;N Murray;K Gelmon;M McKenzie;F Wong;J Morris;C Grafton;A Shah;V Tsang;K Goddard;K Murphy;B Sheehan;C. Parsons;R Amy;R Page Proc of the American Society of Clinical Oncology 15(#1125):377

Other Clinical Trials

SWOG Clinical Trial Number
CTSU/EA5231

A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
SWOG Clinical Trial Number
S2414

INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/A082304/S2402

Perioperative Versus Adjuvant Systemic Therapy In Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG, CTIU2317
Research Committee(s)
Lung Cancer
Activated
12/11/2024
Open